References
- Phillips G L, Herzig R H, Lazarus H M, et al. Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous bone marrow. N Engl J Med 1984; 310: 1557–1561
- Philip T, Armitage J O, Spitzer G, et al. High dose therapy and autologous marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non-Hodgkin's lymphoma. N Engl J Med 1987; 316: 1493–1498
- Takvorian T M, Canellos G P, Ritz J, et al. Prolonged disease free survival after autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med 1987; 316: 1499–1505
- Armitage J O. Bone marrow transplantation in the treatment of patients with lymphoma. Blood 1989; 73: 1749–1758
- Freedman A S, Nadler L M. Which patients with relapsed non-Hodgkin's lymphoma benefit from high dose therapy and hematopoietic stem cell transplantation? (Editorial). J Clin Oncol 1993; 11: 1841–1843
- Fouillard L, Gorin N C, Laporte J Ph, et al. Feasibility of autologous transplantation for early consolidation of follicular non-Hodgkin's lymphoma. Eur J Haematol 1991; 46: 279–284
- Rohatiner A ZS, Johnson P WM, Price G CA, et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 1994; 12: 1177–1184
- Freedman A S, Gribben J G, Neuberg D, et al. High dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 1996; 8: 2780–2786
- Williams C D, Goldstone A H, Pearce R M, et al. Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case matched comparison with unpurged cases by the European blood and marrow transplant lymphoma registry. J Clin Oncol 1996; 14: 2454–2464
- Columbat P, Donaldo D, Fouillard F, et al. Value of autologous bone marrow transplantation in follicular lymphoma: A France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant 1994; 13: 157–162
- Stein R S, Greer J P, Goodman S, et al. High dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin. Bone Marrow Transplant 1999; 23: 227–233
- Stein R S, Greer J P, Goodman S, et al. Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade lymphoma. Bone Marrow Transplant 2000; 25: 7–262
- Stein R S, Greer J P, Goodman S, et al. Limited efficacy of intensified preparative regimens in autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma. Leukemia and Lymphoma
- Velasquez W S, Cabanillas Salvador P, et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ARA-C and dexamethasone (DHAP). Blood 1988; 71: 117–122
- Velasquez W S, McLaughlin P, Tucker S, et al. ESHAP-An effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 1994; 12: 1169–1176
- Kaplan E L, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
- Bierman P J, Vose J M, Anderson J R, et al. High dose therapy with autologous hematopoietuc rescue for follicular low grade non-Hodgkin's lymphoma. J Clin Oncol 1997; 15: 445–450
- Nademanee A, Molina A, Dagis A C, et al. High-dose therapy and autologous stem cell transplantation (ASCT) for poor risk and relapsed non-Hodgkin's lymphoma (NHL): Long term follow-up results and analysis of prognostic factors in 369 patients. Blood 1999; 94(Suppl 1)170a, abstract